Filtered By:
Condition: Patent Foramen Ovale
This page shows you your search results in order of relevance. This is page number 5.
Order by Relevance | Date
Total 1415 results found since Jan 2013.
Risk of recurrent ischemic stroke in patients with patent foramen ovale: The role of D-dimer
Paradoxical embolism under elevated thromboembolic conditions is known to be the primary mechanism of patent foramen ovale (PFO)-related stroke. We hypothesized that higher levels of D-dimer, a marker of thromboembolism, could increase the risk of stroke recurrence in patients with PFO.
Source: Journal of Stroke and Cerebrovascular Diseases - August 1, 2023 Category: Neurology Authors: Seongho Park, Boseong Kwon, Jin Kyung Oh, Jae-Kwan Song, Ji Sung Lee, Sun U. Kwon Source Type: research
Letter by Furlan Regarding "Critique of Closure or Medical Therapy for Cryptogenic Stroke With Patent Foramen Ovale: The Hole Truth?" Letters to the Editor
Source: Stroke - January 18, 2013 Category: Neurology Authors: Furlan, A. J. Tags: Catheter-based coronary and valvular interventions: other, Embolic stroke, Cardiac development Letters to the Editor Source Type: research
Ischemic stroke after pellet embolization
A 9-year-old boy was shot with a pellet shotgun and developed a visual field deficit. Head CT revealed a pellet in the left ambien cistern, in the left posterior cerebral artery on catheter angiography (figure). Chest fluoroscopy revealed multiple thoracic pellets, including a mobile cardiac pellet (video on the Neurology® Web site at Neurology.org). There was no clear cardiac injury, patent foramen ovale, or skull penetration. Arterial embolization of a pellet from the chest to the intracranial vasculature likely caused a stroke.1,2 We considered arteriotomy, endovascular retrieval, and medical therapy. The establishe...
Source: Neurology - June 8, 2015 Category: Neurology Authors: Aghaebrahim, A., Giurgiutiu, D.-V., Jankowitz, B. T., Jovin, T., Jadhav, A. P. Tags: All Cerebrovascular disease/Stroke, Embolism VIDEO NEUROIMAGES Source Type: research
Stroke in the Young: Patent Foramen Ovale and Pregnancy Illustrative Teaching Cases
Source: Stroke - July 27, 2015 Category: Neurology Authors: Miller, B. R., Strbian, D., Sundararajan, S. Tags: Anticoagulants, Antiplatelets, Other Stroke Treatment - Surgical Illustrative Teaching Cases Source Type: research
Recurrent Stroke due to Patent Foramen Ovale Closure Device Thrombus Eight Years after Implantation
We present a case of cardioembolic stroke secondary to a mobile thrombus on a PFO closure device 8 years after implantation.
Source: Journal of Stroke and Cerebrovascular Diseases - July 17, 2016 Category: Neurology Authors: Thomas V. Kodankandath, Sanskriti Mishra, Richard B. Libman, Paul Wright Tags: Case Studies Source Type: research
Thrombolysis for Ischemic Stroke during Pregnancy: A Case Report and Review of the Literature
We report the successful use of intravenous alteplase (tissue plasminogen activator; tPA) thrombolysis in a pregnant woman with acute cardioembolic stroke presumed to be paradoxical embolism through a patent foramen ovale.
Source: Journal of Stroke and Cerebrovascular Diseases - August 10, 2016 Category: Neurology Authors: Steven Tversky, Richard B. Libman, Marina L. Reppucci, Andrea M. Tufano, Jeffrey M. Katz Tags: Case Studies Source Type: research
Tissue Plasminogen Activator to Treat a Stroke after Foam Sclerotherapy in a Woman with a Patent Foramen Ovale
Although foam sclerotherapy to varicose veins is now a popular treatment because of its high efficacy and safety, some neurologic complications have recently been reported. Presently, the effectiveness and safety of intravenous recombinant tissue-type plasminogen activator therapy to stroke following foam sclerotherapy remain unclear. Here, we report the case of a 68-year-old woman whose ischemic symptoms following foam sclerotherapy were treated by intravenous recombinant tissue-type plasminogen activator.
Source: Journal of Stroke and Cerebrovascular Diseases - February 2, 2018 Category: Neurology Authors: Kosuke Matsuzono, Naoto Arai, Masayuki Suzuki, Younhee Kim, Tadashi Ozawa, Takafumi Mashiko, Haruo Shimazaki, Reiji Koide, Tohru Matsuura, Shigeru Fujimoto Tags: Case Studies Source Type: research
Letter by Chen et al Regarding Article, “Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis” Letter to the Editor
Source: Stroke - April 23, 2018 Category: Neurology Authors: Xi Chen, Shidong Chen, Qiang Dong Tags: Cerebrovascular Disease/Stroke Letters to the Editor Source Type: research
Response by Ntaios et al to Letter Regarding Article, “Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis” Letter to the Editor
Source: Stroke - April 23, 2018 Category: Neurology Authors: George Ntaios, Thorsten Steiner, Patrik Michel Tags: Cerebrovascular Disease/Stroke Letters to the Editor Source Type: research
Letter by Doshi et al Regarding Article, “Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis” Letter to the Editor
Source: Stroke - April 23, 2018 Category: Neurology Authors: Rajkumar Doshi, Neelesh Gupta, Vineet Meghrajani Tags: Cerebrovascular Disease/Stroke, Transient Ischemic Attack (TIA) Letters to the Editor Source Type: research
Response by Ntaios et al to Letter Regarding Article, “Closure of Patent Foramen Ovale Versus Medical Therapy in Patients With Cryptogenic Stroke or Transient Ischemic Attack: Updated Systematic Review and Meta-Analysis” Letter to the Editor
Source: Stroke - April 23, 2018 Category: Neurology Authors: George Ntaios, Thorsten Steiner, Patrik Michel Tags: Ischemic Stroke Letters to the Editor Source Type: research
Tissue Plasminogen Activator to Treat a Stroke after Foam Sclerotherapy in a Woman with a Patent Foramen Ovale
Although foam sclerotherapy to varicose veins is now a popular treatment because of its high efficacy and safety, some neurologic complications have recently been reported. Presently, the effectiveness and safety of intravenous recombinant tissue-type plasminogen activator therapy to stroke following foam sclerotherapy remain unclear. Here, we report the case of a 68-year-old woman whose ischemic symptoms following foam sclerotherapy were treated by intravenous recombinant tissue-type plasminogen activator.
Source: Journal of Stroke and Cerebrovascular Diseases - February 2, 2018 Category: Neurology Authors: Kosuke Matsuzono, Naoto Arai, Masayuki Suzuki, Younhee Kim, Tadashi Ozawa, Takafumi Mashiko, Haruo Shimazaki, Reiji Koide, Tohru Matsuura, Shigeru Fujimoto Tags: Case Studies Source Type: research
Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke Topical Review
Source: Stroke - May 25, 2018 Category: Neurology Authors: Jeffrey L. Saver, Heinrich P. Mattle, David Thaler Tags: Congenital Heart Disease, Treatment, Ischemic Stroke Topical Reviews Source Type: research
Carotid Atherosclerosis and Patent Foramen Ovale in Embolic Stroke of Undetermined Source
Carotid atherosclerosis and likely pathogenic patent foramen ovale (PFO) are two potential embolic sources in patients with embolic stroke of undetermined source (ESUS). The relationship between these two mechanisms among ESUS patients remains unclear.
Source: Journal of Stroke and Cerebrovascular Diseases - October 30, 2020 Category: Neurology Authors: George Ntaios, Dimitrios Sagris, Davide Strambo, Kalliopi Perlepe, Gaia Sirimarco, Georgios Georgiopoulos, Stefania Nannoni, Eleni Korompoki, Efstathios Manios, Konstantinos Makaritsis, Konstantinos Vemmos, Patrik Michel Source Type: research
